Biomaterials availability: potential effects on medical innovation and health care
Rand, 2000 - Medical - 61 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Supplier Exit from the Market
Patients Perspectives on a Biomaterials Shortage
Access Assurance Act analysis Aronoff Associates 1994 availability of biomaterials bankruptcy Bethesda bioceramics biocompatibility Biomaterials Access Assurance Biomaterials Availability Coalition biomaterials for medical biomaterials shortage biomaterials suppliers bone Breast Implant Litigation breast implants caprolactone catheters clinical companies court Cowley decisions device manufacturers disease Dow Chemical Dow Corning Dow Corning's DuPont effects engineering and cell future patients heart valves HIMA Homsy hydrocephalus shunts implant patients implantable devices implantable medical devices important include implants Institutes of Health lawsuits materials suppliers medical applications Medical Implant Medtronic million National Institutes orthopedic components orthopedic prostheses overall benefits P.O. Box pacemaker percent perspectives Ph.D polymers polytetrafluoroethylene potential shortage product liability Proplast prostheses PTFE RAND research and development responsible risk Robert Langer Rockledge S&T Policy Institute Schmucki Science and Technology shortage of biomaterials SILASTIC Technology Policy Institute Teflon tissue engineering TMJ Implant tort system Vitek Washington Wilkerson Group 1995